US health authorities on Tuesday recommended pausing the Johnson & Johnson COVID shot over blood clot fears, with the company quickly announcing it would delay its European rollout, in a setback for global immunization campaigns.
US health authorities on Tuesday recommended pausing the Johnson & Johnson COVID shot over blood clot fears, with the company quickly announcing it would delay its European rollout, in a setback for global immunization campaigns.
